Calseña, Glaiza .

HRN: 27-04-67  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2025
CEFUROXIME 1.5GM (VIAL)
05/13/2025
05/13/2025
IV
1500mg
On Call To OR
For LTCS
Waiting Final Action 
05/13/2025
AMPICILLIN 1GM (VIAL)
05/13/2025
05/19/2025
IV
2 Grams
Every 6 Hours
Premature Rupture Of Membranes
Waiting Final Action 
05/13/2025
CEFUROXIME 1.5GM (VIAL)
05/13/2025
05/14/2025
IVT
Q8h
X 3 Doses
S/p CS
Waiting Final Action 
05/13/2025
CEFUROXIME 500MG (TAB)
05/13/2025
05/20/2025
PO
500mg
BID
S/p CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: